Savara, Inc. (SVRA)
5.33
-0.04
(-0.74%)
USD |
NASDAQ |
Sep 04, 10:43
Savara Cash and Short Term Investments (Annual) : 235.70M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 235.70M |
| December 31, 2024 | 196.33M |
| December 31, 2023 | 162.32M |
| December 31, 2022 | 125.88M |
| December 31, 2021 | 161.17M |
| December 31, 2020 | 82.19M |
| December 31, 2019 | 121.77M |
| December 31, 2018 | 110.83M |
| December 31, 2017 | 94.35M |
| December 31, 2016 | 13.37M |
| December 31, 2015 | 40.98M |
| December 31, 2014 | 57.29M |
| December 31, 2013 | 44.39M |
| Date | Value |
|---|---|
| December 31, 2012 | 36.51M |
| December 31, 2011 | 50.70M |
| December 31, 2010 | 27.98M |
| December 31, 2009 | 8.667M |
| December 31, 2008 | 9.850M |
| December 31, 2007 | 33.46M |
| December 31, 2006 | 51.75M |
| December 31, 2005 | 22.59M |
| December 31, 2004 | 13.03M |
| December 31, 2003 | 4.226M |
| December 31, 2002 | 0.1039M |
| December 31, 2001 | 0.1645M |
| December 31, 2000 | 1.484M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Gilead Sciences, Inc. | 9.613B |
| Insmed, Inc. | 1.430B |
| United Therapeutics Corp. | 2.920B |
| Vertex Pharmaceuticals, Inc. | 6.611B |
| SELLAS Life Sciences Group, Inc. | 71.89M |